Suppr超能文献

巴塞罗那肠热病:输入性病例的变化模式和抗生素耐药性。

Enteric fever in Barcelona: Changing patterns of importation and antibiotic resistance.

机构信息

Barcelona Institute for Global Health, ISGlobal-CRESIB, Universitat de Barcelona, Spain.

Barcelona Institute for Global Health, ISGlobal-CRESIB, Universitat de Barcelona, Spain.

出版信息

Travel Med Infect Dis. 2016 Nov-Dec;14(6):577-582. doi: 10.1016/j.tmaid.2016.11.009. Epub 2016 Nov 24.

Abstract

BACKGROUND

Enteric fever's incidence is decreasing among residents of high-income countries, although it's rising in travelers coming from low-resource endemic settings. The study's aim is to describe epidemiological, clinical and laboratory features of patients with enteric fever.

METHODS

Retrospective descriptive study of enteric fever cases diagnosed at a Tropical Medicine Unit in Barcelona, 1993-2012.

RESULTS

Out of 40 patients, 31(77,5%) were returning travelers, and 70% of them had been in Southern Asia. In the rest of patients without an antecedent of a recent travel, the infection occurred mainly before year 2000. The more frequently reported symptoms were fever and diarrhea, lacking significant differences between S. typhi and S. paratyphi infections. Quinolones were used as empiric treatment in 47.2% of patients, 36.1% received 3rd generation cephalosporins, 2.78% azithromycin and 13.89% other combinations. Resistance to quinolones in the S. paratyphi group (66.7%) was significantly higher compared with the S. typhi group (20%) (p:0.02). 22.5% of patients had treatment failure and 23.6% patients presented complications, none of them had been previously vaccinated.

CONCLUSIONS

The diagnosis of enteric fever was more frequent among travelers coming from Southern-East Asia. Quinolone resistance is widely spread, particularly in S. paratyphi serotypes and should not be considered as first choice treatment anymore.

摘要

背景

在高收入国家,肠热病的发病率正在下降,尽管从资源匮乏的地方性疫区返回的旅行者中发病率正在上升。本研究旨在描述肠热病患者的流行病学、临床和实验室特征。

方法

对巴塞罗那热带医学系 1993 年至 2012 年诊断的肠热病病例进行回顾性描述性研究。

结果

40 例患者中,31 例(77.5%)为返回旅行者,其中 70%曾前往南亚。在其余无近期旅行史的患者中,感染主要发生在 2000 年之前。发热和腹泻是较常报告的症状,在伤寒和副伤寒感染之间无显著差异。47.2%的患者经验性使用喹诺酮类药物治疗,36.1%使用第三代头孢菌素,2.78%使用阿奇霉素,13.89%使用其他联合药物。副伤寒血清型组对喹诺酮类药物的耐药率(66.7%)明显高于伤寒血清型组(20%)(p:0.02)。22.5%的患者治疗失败,23.6%的患者出现并发症,均未接种过疫苗。

结论

来自东南亚的旅行者中肠热病的诊断更为常见。喹诺酮类药物耐药性广泛传播,特别是在副伤寒血清型中,不应再将其作为首选治疗药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验